Overview

SUBLIVAC FIX Birch Phase III Short-term Efficacy

Status:
Completed

Trial end date:
2015-11-01

Target enrollment:

Participant gender:

Summary

The aim of this phase III study is to asses if SUBLIVAC FIX Birch is safe and effective in reducing birch allergy induced symptoms and birch allergy medication usage.

Phase:

Phase 3

Details

Lead Sponsor:

HAL Allergy